Buy, hold, sell: Echo IQ, Bluescope Steel, Lovisa shares

Here are some new expert recommendations on three ASX stocks.

S&P/ASX 200 Index (ASX: XJO) shares are 0.8% lower at 8,691.8 points on Thursday.

Here are some new expert recommendations on three ASX stocks.

Comical investor reading documents and surrounded by calculators.

Image source: Getty Images

Lovisa Holdings Ltd (ASX: LOV)

The Lovisa share price is steady at $24.52 today, and down 36% over 12 months. 

Bell Potter upgraded this ASX consumer discretionary share from hold to buy.

The broker kept its price target at $27.

Analyst Chami Ratnapala said: 

While we remain cautious on the current weak consumer landscape and investments into market share & store refits to mitigate competitive pressures in key markets, we see a higher tolerance re accessibility from a low price point perspective together with a strong gross margin.

Post the market sell-off, we think the current valuation at ~22x FY27e P/E (BPe) which is a ~20% discount to LOV's recent mid-cycle P/E as BPe of 28.5x appears attractive, and we upgrade our recommendation to BUY.

BlueScope Steel Ltd (ASX: BSL)

The Bluescope share price is $30.44, up 1.4% today and up 35% over 12 months. 

Andrew Wielandt from DP Wealth Advisory has a hold rating on this ASX 200 materials share. 

Wielandt said (courtesy The Bull):  

BlueScope delivered a strong result in full year 2026. Underlying earnings before interest and tax increased to $1.273 billion, supported by stronger US steel production, margins and a record Southeast Asian performance.

Management delivers disciplined cost management. We expect free cash flow to improve and and support total shareholder returns.

However, BSL remains a cyclical business. Despite the business performing well, the operating environment remains volatile, which is behind our hold recommendation.

Echo IQ Ltd (ASX: EIQ)

The Echo IQ share price is 69 cents, up 7% today and up 260% over 12 months. 

Bell Potter downgraded this ASX tech share from speculative hold to speculative sell.

The broker slashed its 12-month price target from $1.75 to 30 cents.

Analyst John Hester said:

The company's 510(k) application for registration of EchoSolv HF has been rejected by the FDA.

The agency issued a detailed 'Not Substantially Equivalent' notice which describes the reasons for its decision.

The company revealed little regarding the contents of the NSE and only highlighted disagreement on matters of statistical
analysis.

EIQ intends to hold further dialogue with the Agency in order to determine if there is a path forward, hence it created an expectation for a future approval either via a resubmission of the 510(k) or alternative registration pathway.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa. The Motley Fool Australia has recommended Lovisa. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Couple using their digital tablet together.
Broker Notes

Buy, hold, sell: New Hope, REA, Telix Pharmaceuticals shares

Three experts share their views on three ASX 200 shares.

Read more »

Boys making faces and flexing.
Broker Notes

Buy, hold, sell: Telstra, AGL, PLS shares

Brokers give their latest verdicts on these ASX shares.

Read more »

Two men standing with a tablet at a grain farm.
Broker Notes

What is Bell Potter's updated view on Nufarm shares after crashing 6%

It could be time to buy the dip.

Read more »

A man has a surprised and relieved expression on his face.
Broker Notes

Guess which ASX share could rise 130%

Bell Potter is tipping this share to rocket.

Read more »

A happy group of workers around a table raise their arms in the air as though celebrating a work achievement. One woman is on her feet with her arm raised in the air in a fist-pumping action.
Broker Notes

Viva Energy, Codan, AMP shares reach 52-week highs: How much higher can they go?

Here's what brokers expect next.

Read more »

Red percentage sign in front of a chart.
Broker Notes

Where to invest as interest rates charge higher

A hike next week is all but locked in.

Read more »

Three people run in a race through deep mud and puddles of water.
Broker Notes

Buy, sell, hold: AMP, Wesfarmers, Woodside shares

Find out what brokers tip next for these ASX 200 shares.

Read more »

A jockey gets down low on a beautiful race horse as they flash past in a professional horse race with another competitor and horse a little further behind in the background.
Broker Notes

RBC Capital Markets thinks Tabcorp shares could go how high?

These shares are looking like a good bet.

Read more »